kabutan

Medrx Co.,Ltd., July-September (3Q) Net Income Loss Widens

Fri Nov 8, 2024 3:30 pm JST Earnings

4586 Medrx Co.,Ltd. 【J-GAAP】

Earnings Report

Medrx Co.,Ltd. <4586> [TSE-G] announced its financial results after the market closed on November 8th (15:30). The consolidated net loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) was a reduced loss of 320 million yen (compared to a loss of 671 million yen in the same period last year).

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the October to December period (4Q) is expected to expand to a loss of 526 million yen (compared to a loss of 261 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated net loss expanded to a loss of 259 million yen (compared to a loss of 190 million yen in the same period last year). The operating profit/loss margin drastically worsened from -834.8% in the same period last year to -1016.7%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 9 -621 -636 -635 -25.8 ー Nov 11, 2022 J-GAAP
Jan - Sep, 2023 29 -670 -668 -671 -20.0 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 255 -379 -343 -320 -7.6 ー Nov 8, 2024 J-GAAP
YoY +779.3% +43.4% +48.7% +52.3% +62.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 23 -455 -450 -451 -13.0 0 Feb 9, 2024 J-GAAP
Jul - Dec, 2024 Guidance 28 -784 -784 -785 -16.6 0 Aug 9, 2024 J-GAAP
YoY +21.7% -72.3% -74.2% -74.1% -27.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 59 -1,098 -1,112 -1,111 -43.8 0 Feb 10, 2023 J-GAAP
Dec, 2023 29 -933 -930 -932 -26.8 0 Feb 9, 2024 J-GAAP
Dec, 2024 Guidance 259 -919 -868 -846 -17.9 0 Aug 9, 2024 J-GAAP
YoY +793.1% +1.5% +6.7% +9.2% +33.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 23 -192 -188 -190 -5.7 -834.8 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 0 -263 -262 -261 -7.5 -Inf Feb 9, 2024 J-GAAP
Jan - Mar, 2024 0 -176 -127 -128 -3.3 -Inf May 10, 2024 J-GAAP
Apr - Jun, 2024 231 41 43 67 1.7 17.7 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 24 -244 -259 -259 -6.2 -1,016.7 Nov 8, 2024 J-GAAP
YoY +4.3% -27.1% -37.8% -36.3% -8.7%

Related Articles